Evidence map›Paper›PMID 40079278›Full record

ArticleJournal of the American Heart Association2025

Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does Heart Failure With Supranormal Ejection Fraction Exist? Data From the Swedish Heart Failure Registry.

Laura Landucci, Ulrika Ljung Faxén, Lina Benson, Giuseppe M C Rosano, Ulf Dahlström, Lars H Lund, Gianluigi Savarese

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Laura LanducciDivision of Cardiology, Department of Medicine Karolinska Institutet Stockholm Sweden.ORCID 0009-0007-4656-1830
Ulrika Ljung FaxénDivision of Cardiology, Department of Medicine Karolinska Institutet Stockholm Sweden.ORCID 0000-0002-0223-1588
Lina BensonDivision of Cardiology, Department of Medicine Karolinska Institutet Stockholm Sweden.ORCID 0000-0002-5393-0055
Giuseppe M C RosanoIRCCS San Raffaele Cassino Cassino Italy.ORCID 0000-0003-4023-2263
Ulf DahlströmDepartment of Cardiology and Department of Health, Medicine and Caring Sciences Linkoping University Linkoping Sweden.ORCID 0000-0001-6353-8041
Lars H LundDivision of Cardiology, Department of Medicine Karolinska Institutet Stockholm Sweden.ORCID 0000-0003-1411-4482
Gianluigi SavareseDepartment of Clinical Science and Education Södersjukhuset, Karolinska Institutet Stockholm Sweden.ORCID 0000-0001-7732-0887

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSparce data suggest higher mortality in heart failure (HF) with left ventricular ejection fraction (EF) >65% to 70%. We characterized EF distribution, characteristics, and outcomes in patients with HF and EF ≥50%. METHODS AND

resultsThere were 5576 patients enrolled in the Swedish HF registry between 2017 and 2021 and included in the study; 21% had EF ≥60%, 5% EF ≥65%, and 1.5% EF ≥70%. Patient characteristics independently associated with EF ≥60% were assessed by multivariable logistic regression and were identified as being a diagnosis of hypertrophic cardiomyopathy, worse New York Heart Association class, hypertension, and valvular disease, whereas use of medications and devices also recommended for HF with reduced EF, male sex, history of ischemic heart disease, peripheral artery disease, and chronic obstructive pulmonary disease were associated with an EF of 50% to 59%. Outcomes (all-cause, cardiovascular, and noncardiovascular death; all-cause and HF hospitalizations) were assessed by univariable and multivariable Cox regressions with EF modeled as a spline. The risk of all-cause and noncardiovascular mortality and first all-cause hospitalization was higher with EF values >55% in crude but not adjusted analyses.

conclusionsAmong patients with HF with preserved EF, 21% had EF ≥60%. A higher EF was characterized by more severe symptoms, hypertrophic cardiomyopathy, hypertension, female sex, and valvular disease. Crude higher but not adjusted risk of all-cause and noncardiovascular mortality and of all-cause hospitalization was observed with EF values >55%, suggesting that prognostically impactful conditions were more prevalent in the upper bound of the EF spectrum.

Indexed as

Heart FailureStroke VolumeVentricular Function, LeftAgedAged, 80 and overCause of DeathFemaleHospitalizationHumansMaleMiddle AgedPrognosisRegistriesRisk FactorsSwedenheart failureheart failure with preserved ejection fractionheart failure with supranormal ejection fractionregistrySwedeHF

Identifiers

PMID40079278
PMCPMC12132690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.